Skip to main content

Medical Services

A life sciences company that is testing a sustained-release risperidone product for psychosis is now pursuing an effort to improve adherence to naltrexone for opioid dependence.
A report released today by Quest Diagnostics and the Center on Addiction shows some inconsistencies between physician perspectives and patient behaviors regarding prescription drug use.
Initial research is helping to confirm Hazelden Betty Ford Foundation's move to established focused treatment for opioid addiction that includes extended medication treatment.
Fentanyl overdose deaths climbed 14% in 2018, per CDC data, and a report released this week by not-for-profits Drug Strategies and Shatterproof studies the states hit hardest and how they have responded.
The Hampden County, Mass., corrections system has moved fully into medication-assisted treatment for inmates with substance use disorders, a practice that can be instructive for other jail systems.
Click here and listen to Dr. Patricia Essilfie, a physician at St. John’s Well Child, as she describes how the once limited resources and treatment plans for smokers at St. John’s, were transformed…
Back to Top